Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Minerva Neurosciences, Inc. Director's Dealing 2015

Apr 16, 2015

35086_dirs_2015-04-16_efa41b23-2ea3-4ba8-91af-0a068f59789d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2015-04-14

Reporting Person: Race Geoff (EVP & Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-04-14 Stock Option (right to buy) $5.19 A 213133 Acquired 2025-04-13 Common Stock (213133) Direct

Footnotes

F1: The exercise price is the closing price of the Issuer's common stock on April 14, 2015.

F2: This option shall vest as follows: 25% on April 14, 2016; and then in quarterly installments over 3 years thereafter.